Canada - English - Health Canada

bristol-myers squibb canada - mavacamten - capsule - 5mg - mavacamten 5mg

Canada - English - Health Canada

bristol-myers squibb canada - mavacamten - capsule - 10mg - mavacamten 10mg

Canada - English - Health Canada

bristol-myers squibb canada - mavacamten - capsule - 15mg - mavacamten 15mg

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - mavacamten - capsule - mavacamten 10.0mg

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - mavacamten - capsule - mavacamten 15.0mg

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - mavacamten - capsule - mavacamten 2.5mg

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - mavacamten - capsule - mavacamten 5mg

Israel - English - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 10 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms

Israel - English - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 15 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms

Israel - English - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 2.5 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms